Uncharacterized 24.7 kDa protein in gap 5'region Antibody

What is the Uncharacterized 24.7 kDa protein in gap 5'region?

The Uncharacterized 24.7 kDa protein in gap 5'region (UniProt: P20296) is a protein of unknown function identified in the archaeon Pyrococcus woesei, a hyperthermophilic archaeon. As with many uncharacterized proteins, its molecular function, biological processes, and cellular localization remain to be elucidated through targeted research approaches. The antibody against this protein provides researchers with a tool to begin characterization studies using various immunological techniques including ELISA and Western blotting .

What experimental applications are validated for this antibody?

Based on manufacturer specifications, this antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . These immunoassay techniques allow for protein detection and quantification in various sample types. While the antibody is generated against a bacterial (archaeal) target, researchers should conduct preliminary validation studies to confirm its performance in their specific experimental systems and to determine optimal working conditions.

What are the physical and technical properties of this antibody?

The antibody has the following specifications:

This information provides essential technical parameters for researchers planning experiments with this antibody .

How should researchers design validation experiments for antibodies against uncharacterized proteins?

When working with antibodies against uncharacterized proteins, validation is particularly critical:

• Specificity testing:

  • Perform Western blot analysis with recombinant protein as a positive control

  • Conduct peptide competition assays where the antibody is pre-incubated with excess immunizing peptide before application

  • Include knockout or knockdown controls where possible

• Titration experiments:

  • Test multiple antibody concentrations to determine optimal signal-to-noise ratio

  • For Western blots, typically start with 1:500-1:5000 dilutions

  • For ELISA, perform serial dilutions from 1:100-1:10,000

• Cross-reactivity assessment:

  • Test the antibody against lysates from organisms lacking homologs

  • Evaluate potential binding to proteins with similar structural domains

This methodological approach aligns with established practices for antibody validation in research settings .

What controls are essential when using this antibody for research?

Essential controls for experiments with antibodies against uncharacterized proteins include:

Including these controls helps ensure experimental rigor and supports the validity of results obtained with this antibody .

What approaches can help characterize the function of uncharacterized proteins?

Modern functional characterization of uncharacterized proteins employs a multi-faceted approach:

• Computational prediction:

  • Use AlphaFold2 and similar deep learning tools to predict protein structure

  • Employ functional annotation tools to identify potential domains and motifs

  • Perform phylogenetic analysis to identify evolutionary relationships with characterized proteins

• Experimental characterization:

  • Use the antibody for co-immunoprecipitation to identify interaction partners

  • Perform subcellular localization studies using immunofluorescence

  • Conduct expression analysis across different conditions to identify regulatory patterns

• Manual data mining workflows:

  • Implement systematic workflows like "Functionathon" that combine predicted and experimental information

  • Generate functional hypotheses based on predicted properties, interactions, expression patterns, and conservation

These approaches collectively provide a systematic pathway to elucidate the function of previously uncharacterized proteins .

How can mass spectrometry complement antibody-based studies of uncharacterized proteins?

High-resolution native mass spectrometry (native MS) offers powerful complementary approaches:

• Structural characterization:

  • Analyze intact protein complexes to determine stoichiometry

  • Assess conformational states under different conditions

  • Identify post-translational modifications that may regulate function

• Proteoform profiling:

  • Native MS can identify different variants of the uncharacterized protein

  • Characterize modification patterns that might not be detectable by antibody-based methods

  • Assess structural heterogeneity in the protein population

• Validation of antibody-based findings:

  • Confirm the identity of proteins detected by the antibody

  • Verify the specificity of the antibody through orthogonal measurement

  • Characterize the complete composition of protein complexes isolated by immunoprecipitation

The integration of mass spectrometry with antibody-based approaches provides a more comprehensive characterization of uncharacterized proteins .

What protein-protein interaction methodologies are most suitable for uncharacterized proteins?

For studying interactions involving uncharacterized proteins, several methodologies are particularly valuable:

• Antibody-based approaches:

  • Co-immunoprecipitation using the uncharacterized protein antibody followed by mass spectrometry

  • Proximity-dependent labeling methods (BioID, APEX) to identify neighboring proteins

  • Far-Western blotting to detect direct interactions with candidate partners

• Experimental considerations:

  • Use crosslinking agents to stabilize transient interactions

  • Include appropriate controls to distinguish specific from non-specific interactions

  • Consider native conditions to maintain physiologically relevant protein conformations

• Validation strategies:

  • Confirm key interactions through reciprocal co-immunoprecipitation

  • Use surface plasmon resonance (SPR) to measure binding kinetics, as demonstrated in antibody-antigen interaction studies

  • Employ computational predictions to prioritize candidate interactors for validation

These approaches help build a functional context for uncharacterized proteins through their interaction networks .

How can researchers apply artificial intelligence approaches to study uncharacterized proteins?

AI-driven approaches offer new opportunities for uncharacterized protein research:

• Structure prediction:

  • AlphaFold2 can predict protein structures with high accuracy, even for proteins with limited homology to characterized proteins

  • These predictions can inform antibody epitope accessibility and potential functional domains

• Reverse vaccinology applications:

  • AI tools can identify potential functional significance of uncharacterized proteins

  • For example, the study of hypothetical proteins in Neisseria using AI-driven reverse vaccinology demonstrates how computational approaches can prioritize proteins of interest

• Functional prediction:

  • Machine learning models integrating multiple data types can predict protein function

  • These predictions can guide targeted experimental approaches using antibodies like the Uncharacterized 24.7 kDa protein antibody

• Epitope prediction:

  • AI tools like ElliPro can predict B-cell epitopes based on 3D protein structure

  • This information can help researchers understand the binding properties of antibodies against uncharacterized proteins

AI approaches provide a valuable framework for generating testable hypotheses about uncharacterized proteins .

How can researchers assess potential cross-reactivity of antibodies against uncharacterized proteins?

Cross-reactivity assessment is particularly important for antibodies against uncharacterized proteins:

• Sequential testing approach:

  • Start with Western blot against the recombinant antigen to confirm recognition

  • Test against lysates from different species to assess cross-species reactivity

  • Perform epitope mapping to identify the specific binding regions

• Comprehensive testing methodology:

  • Use peptide arrays to identify potential cross-reactive epitopes

  • Perform competitive binding assays with related proteins

  • Conduct immunoprecipitation followed by mass spectrometry to identify all captured proteins

• Analysis considerations:

  • Compare observed binding patterns with sequence homology predictions

  • Consider structural similarity beyond sequence homology

  • Evaluate binding under both native and denaturing conditions

This systematic approach helps establish the specificity boundaries of antibodies against uncharacterized proteins .

What strategies can help overcome non-specific binding issues when working with this antibody?

Non-specific binding can be addressed through systematic optimization:

• Buffer optimization:

  • Adjust salt concentration to reduce ionic interactions (typically 150-500 mM NaCl)

  • Include detergents at appropriate concentrations (0.05-0.1% Tween-20 or Triton X-100)

  • Add blocking proteins not related to the target species (5% BSA or milk)

• Antibody parameters:

  • Titrate antibody concentration to find optimal signal-to-noise ratio

  • Test different incubation times and temperatures

  • Consider antibody purification options if needed

• Sample preparation optimization:

  • For archaeal proteins, consider specialized lysis conditions compatible with thermophilic organisms

  • Pre-clear samples to remove components that cause non-specific binding

  • Include additional blocking agents specific to the sample type

These methodological refinements can significantly improve the specificity of experimental results .

How do researchers distinguish between specific binding and background when working with uncharacterized proteins?

Distinguishing specific from non-specific signals requires systematic controls:

• Control hierarchy implementation:

  • Include multiple types of controls in parallel experiments

  • Compare signals between primary antibody, pre-immune serum, and secondary-only conditions

  • Use peptide competition to confirm epitope specificity

• Quantitative assessment:

  • Perform densitometry analysis on Western blots

  • Calculate signal-to-noise ratios across different experimental conditions

  • Apply statistical tests to determine significance of observed differences

• Technical considerations:

  • Optimize exposure times to prevent saturation while maintaining sensitivity

  • Use replicate experiments to assess reproducibility

  • Consider alternative detection methods (chemiluminescence vs. fluorescence) to confirm results

This methodological approach establishes a framework for confident interpretation of results with antibodies against uncharacterized proteins .

How can this antibody be used in functional genomics studies?

This antibody can serve as a valuable tool in functional genomics research:

• Protein expression profiling:

  • Map expression patterns across different conditions

  • Correlate protein levels with transcriptomic data

  • Identify regulatory conditions that affect protein abundance

• Localization studies:

  • Determine subcellular localization in native or heterologous expression systems

  • Track potential relocalization under different conditions

  • Compare localization patterns with predicted targeting sequences

• Integration with other genomic approaches:

  • Use antibody-based detection to validate findings from high-throughput screens

  • Correlate protein detection with phenotypic effects of genetic manipulation

  • Integrate antibody-generated data with computational predictions

These applications contribute to building a functional profile of uncharacterized proteins within broader genomic contexts .

What analytical techniques can determine if the uncharacterized protein contains post-translational modifications?

Detecting post-translational modifications (PTMs) requires specialized approaches:

• Immunological methods:

  • Use the antibody for immunoprecipitation followed by PTM-specific antibody detection

  • Analyze mobility shifts in Western blots that might indicate modifications

  • Compare migration patterns under different sample treatment conditions

• Mass spectrometry integration:

  • Perform immunoprecipitation followed by mass spectrometry

  • Apply specialized PTM enrichment protocols before analysis

  • Use high-resolution native MS to detect intact proteoforms with modifications

• Functional validation:

  • Test activity under conditions that modulate specific PTMs

  • Compare native protein with recombinant versions lacking modification sites

  • Use site-directed mutagenesis to confirm the role of specific modification sites

This multi-technique approach can reveal functional regulatory mechanisms through post-translational modifications .

How can researchers integrate experimental data from this antibody with computational predictions?

Effective integration of experimental and computational data requires systematic approaches:

• Structural validation:

  • Compare antibody accessibility data with predicted protein structures from AlphaFold2

  • Use epitope mapping to confirm structural elements

  • Assess whether antibody binding affects predicted protein-protein interactions

• Functional hypothesis testing:

  • Use computational predictions to design targeted biochemical assays

  • Test predicted interaction partners through co-immunoprecipitation

  • Assess predicted subcellular localization through immunofluorescence

• Data integration frameworks:

  • Apply the "Functionathon" workflow that systematically combines predicted and experimental information

  • Use network-based integration of interaction and expression data

  • Develop machine learning approaches to prioritize hypotheses for experimental testing

This integrated approach maximizes the value of both computational predictions and experimental data generated using the antibody .